Duvelisib

Generic name: Duvelisib
Brand names: Copiktra
Dosage form: oral capsule (15 mg; 25 mg)
Drug class: PI3K inhibitors

Usage of Duvelisib

Duvelisib is used to treat adults with chronic lymphocytic leukemia or small lymphocytic leukemia. Duvelisib is also used to treat follicular lymphoma.

Duvelisib is given after at least two other cancer treatments did not work or have stopped working.

Duvelisib may also be used for purposes not listed in this medication guide.

Duvelisib side effects

Get emergency medical help if you have signs of an allergic reaction (hives, difficult breathing, swelling in your face or throat) or a severe skin reaction (fever, sore throat, burning eyes, skin pain, red or purple skin rash with blistering and peeling).

Duvelisib may cause serious side effects. Call your doctor at once if you have:

severe diarrhea (more than 6 bowel movements in 1 day);

severe stomach pain, new or worsening diarrhea with blood or mucus;

liver problems--stomach pain (upper right side), dark urine, jaundice (yellowing of the skin or eyes); or

low blood cell counts--fever, chills, tiredness, mouth sores, skin sores, easy bruising, unusual bleeding, pale skin, cold hands and feet, feeling light-headed or short of breath.

Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.

Common side effects of duvelisib may include:

diarrhea, nausea;

low blood cell counts;

bone pain, muscle pain;

fever, cough, tiredness; or

cold symptoms such as stuffy nose, sneezing, sore throat.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Duvelisib

Tell your doctor if you have ever had:

an intestinal disorder such as ulcerative colitis;

lung disease; or

liver disease.

Both men and women using duvelisib should use effective birth control to prevent pregnancy. Duvelisib can harm an unborn baby or cause birth defects if the mother or father is using this medicine.

Keep using birth control for at least 1 month after your last dose. Tell your doctor right away if a pregnancy occurs while either the mother or the father is using duvelisib.

It is not safe to breast-feed a baby while you are using this medicine. Also do not breast-feed for at least 1 month after your last dose.

Relate drugs

How to use Duvelisib

Usual Adult Dose for Chronic Lymphocytic Leukemia:

25 mg orally 2 times a day in 28-day cycles until unacceptable toxicity or progressive diseaseComments:-If a dose is missed by fewer than 6 hours, take the missed dose right awayand take the next dose as usual. If a dose is missed by more than 6 hours, waitand take the next dose at the usual time.-Provide prophylaxis for Pneumocystis jirovecii (PJP) during therapy with this drug.-Withhold therapy in patients with suspected PJP of any Grade and discontinue if PJP is confirmed.-Consider prophylactic antivirals during therapy to prevent cytomegalovirus(CMV) infection/reactivation.Uses: For the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) after at least 2 prior therapies

Warnings

Duvelisib can cause serious or fatal side effects, including serious infections, severe diarrhea, or a life-threatening skin rash.

Call your doctor right away if you have symptoms such as:

fever, chills, cough, breathing problems;

severe stomach pain, diarrhea with blood or mucus; o

painful mouth sores, or a skin rash with blistering or peeling.

What other drugs will affect Duvelisib

Sometimes it is not safe to use certain medications at the same time. Some drugs can affect your blood levels of other drugs you take, which may increase side effects or make the medications less effective.

Other drugs may affect duvelisib, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.